• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经调节能否为抗击 COVID19 疫情提供支持?经皮非侵入性迷走神经刺激作为暴发性急性呼吸窘迫综合征的潜在靶向治疗。

Can neuromodulation support the fight against the COVID19 pandemic? Transcutaneous non-invasive vagal nerve stimulation as a potential targeted treatment of fulminant acute respiratory distress syndrome.

机构信息

Stereotactic and Functional Neurosurgery, Department of Neurosurgery, University Hospital Bonn, Germany.

Department of Surgical Sciences, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.

出版信息

Med Hypotheses. 2020 Oct;143:110093. doi: 10.1016/j.mehy.2020.110093. Epub 2020 Jul 18.

DOI:10.1016/j.mehy.2020.110093
PMID:33017913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7368662/
Abstract

The COVID-19 pandemic has rapidly spread all over the world and caused a major health care crisis. About 20% of patients develop severe disease and require hospitalisation, which is associated with a high mortality rate of up to 97% in those being ventilated and respiratory failure being the leading cause of death. Despite many therapeutic agents being under current investigation there is yet no panacea available. With increasing rates of infection throughout the world, there is an urgent need for new therapeutic approaches to counteract the infection. As the nervous system has shown to be a strong modulator of respiratory function and the immune response, we want to highlight pathways involved in regulation of respiratory function, the neuro-immune axis as well as the rationale for a potential targeted treatment of fulminant acute respiratory distress syndrome via transcutaneous non-invasive vagal nerve stimulation in critically-ill COVID-19 patients.

摘要

COVID-19 大流行已迅速在全球范围内蔓延,造成重大的医疗危机。约 20%的患者出现严重疾病并需要住院治疗,这与高达 97%的通气患者死亡率以及呼吸衰竭作为主要死亡原因相关。尽管目前正在研究许多治疗药物,但尚无万能药。随着世界各地感染率的不断上升,急需新的治疗方法来对抗感染。由于神经系统已被证明是呼吸功能和免疫反应的强大调节剂,因此我们想强调参与调节呼吸功能、神经免疫轴的途径以及通过经皮非侵入性迷走神经刺激对危重症 COVID-19 患者进行暴发性急性呼吸窘迫综合征进行潜在靶向治疗的基本原理。

相似文献

1
Can neuromodulation support the fight against the COVID19 pandemic? Transcutaneous non-invasive vagal nerve stimulation as a potential targeted treatment of fulminant acute respiratory distress syndrome.神经调节能否为抗击 COVID19 疫情提供支持?经皮非侵入性迷走神经刺激作为暴发性急性呼吸窘迫综合征的潜在靶向治疗。
Med Hypotheses. 2020 Oct;143:110093. doi: 10.1016/j.mehy.2020.110093. Epub 2020 Jul 18.
2
Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).体外膜肺氧合(ECMO)在 2019 冠状病毒病(COVID-19)肺炎和急性呼吸窘迫综合征(ARDS)危重症患者中的应用。
Med Sci Monit. 2020 Aug 6;26:e925364. doi: 10.12659/MSM.925364.
3
The Use of Non-invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID-19: A Theoretical Hypothesis and Early Clinical Experience.使用非侵入性迷走神经刺激治疗与 COVID-19 相关的呼吸系统症状:一种理论假说和早期临床经验。
Neuromodulation. 2020 Aug;23(6):784-788. doi: 10.1111/ner.13172. Epub 2020 May 12.
4
Awake proning in Covid-19 pneumonia.新型冠状病毒肺炎的清醒俯卧位通气
Infez Med. 2020 Sep 1;28(3):453-455.
5
Optimal therapeutic strategy using extracorporeal membrane oxygenation in patients with COVID-19.新型冠状病毒肺炎患者使用体外膜肺氧合的最佳治疗策略
J Card Surg. 2020 Oct;35(10):2872-2873. doi: 10.1111/jocs.14831.
6
Fibrin-derived peptide Bβ15-42 (FX06) as salvage treatment in critically ill patients with COVID-19-associated acute respiratory distress syndrome.纤维蛋白衍生肽Bβ15 - 42(FX06)作为新型冠状病毒肺炎相关急性呼吸窘迫综合征重症患者的挽救治疗手段
Crit Care. 2020 Sep 24;24(1):574. doi: 10.1186/s13054-020-03293-8.
7
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients.探讨治疗 COVID-19 患者肺炎和急性呼吸窘迫综合征相关细胞因子风暴的药理学方法。
Crit Care. 2020 Jun 11;24(1):331. doi: 10.1186/s13054-020-03020-3.
8
[Prone ventilation for coronavirus disease 2019: an urgent salvage therapy].[2019冠状病毒病的俯卧位通气:一种紧急挽救治疗方法]
Zhonghua Nei Ke Za Zhi. 2020 Sep 1;59(9):670-672. doi: 10.3760/cma.j.cn112138-20200304-00184.
9
Oxygenation device with reservoir and PEEP (ODRPEEP) in patients with acute respiratory distress due to COVID-19.用于新型冠状病毒肺炎所致急性呼吸窘迫患者的带储液器和呼气末正压的氧合装置(ODRPEEP)
Med Clin (Barc). 2020 Aug 14;155(3):133-134. doi: 10.1016/j.medcli.2020.04.010. Epub 2020 May 8.
10
Increased physiological dead space in mechanically ventilated COVID-19 patients recovering from severe acute respiratory distress syndrome: a case report.机械通气的 COVID-19 患者在严重急性呼吸窘迫综合征康复过程中生理性死腔增加:病例报告。
BMC Infect Dis. 2020 Aug 27;20(1):637. doi: 10.1186/s12879-020-05360-5.

引用本文的文献

1
Neuromodulation Strategies to Reduce Inflammation and Improve Lung Complications in COVID-19 Patients.降低新冠肺炎患者炎症并改善肺部并发症的神经调节策略
Front Neurol. 2022 Jul 14;13:897124. doi: 10.3389/fneur.2022.897124. eCollection 2022.
2
Percutaneous Auricular Vagus Nerve Stimulation Reduces Inflammation in Critical Covid-19 Patients.经皮耳迷走神经刺激可减轻重症新冠肺炎患者的炎症反应。
Front Physiol. 2022 Jul 4;13:897257. doi: 10.3389/fphys.2022.897257. eCollection 2022.
3
Non-invasive Vagus Nerve Stimulation for COVID-19: Results From a Randomized Controlled Trial (SAVIOR I).用于治疗 COVID-19 的非侵入性迷走神经刺激:一项随机对照试验(SAVIOR I)的结果
Front Neurol. 2022 Apr 8;13:820864. doi: 10.3389/fneur.2022.820864. eCollection 2022.
4
It Ain't Over 'Til It's Over: SARS CoV-2 and Post-infectious Gastrointestinal Dysmotility.尚未结束:SARS-CoV-2 与感染后胃肠道动力障碍。
Dig Dis Sci. 2022 Dec;67(12):5407-5415. doi: 10.1007/s10620-022-07480-1. Epub 2022 Mar 30.
5
Auricular Neuromodulation for Mass Vagus Nerve Stimulation: Insights From SOS COVID-19 a Multicentric, Randomized, Controlled, Double-Blind French Pilot Study.用于大规模迷走神经刺激的耳神经调制:来自SOS COVID-19一项多中心、随机、对照、双盲法国试点研究的见解
Front Physiol. 2021 Aug 2;12:704599. doi: 10.3389/fphys.2021.704599. eCollection 2021.
6
COVID-19 associated cranial nerve neuropathy: A systematic review.COVID-19 相关颅神经病变:系统评价。
Bosn J Basic Med Sci. 2022 Feb 1;22(1):39-45. doi: 10.17305/bjbms.2021.6341.